RNLXY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RNLXY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).
Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.
Renalytix's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.
For the Health Information Services subindustry, Renalytix's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Margin of Safety % (DCF FCF Based) distribution charts can be found below:
* The bar in red indicates where Renalytix's Margin of Safety % (DCF FCF Based) falls into.
Thank you for viewing the detailed overview of Renalytix's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Howard Jr Doran | officer: Chief Business Officer | C/O HOLOGIC, INC., 35 CROSBY DRIVE, BEDFORD MA 01730 |
Daniel J Levangie | director | 85 SWANSON ROAD, BOXBOROUGH MA 01719 |
Thomas H Mclain | officer: President | NABI PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD N.W., BOCA RATON FL 33487 |
Timothy J Scannell | director | 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002 |
Catherine Coste | director | 966 OCHO RIOS DR, DANVILLE CA 94526 |
Mount Sinai Health System, Inc. | 10 percent owner | 150 EAST 42ND STREET, SUITE 2-B.17, NEW YORK NY 10017 |
Icahn School Of Medicine At Mount Sinai | 10 percent owner | 1 GUSTAVE L. LEVY PLACE, NEW YORK NY 10029 |
Christopher Mills | director, 10 percent owner | C/O RENALYTICS PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
O. James Sterling | officer: Chief Financial Officer | C/O STAR MOUNTAIN CREDIT OPPS FUND, LP, 140 E. 45TH STREET, 37TH FLOOR, NEW YORK NY 10017 |
Mount Sinai Hospitals Group, Inc. | 10 percent owner | ONE GUSTAVE L. LEVY PLACE, NEW YORK NY 10029 |
Sinai Hospital Mount | 10 percent owner | ONE GUSTAVE L LEVY PLACE, NEW YORK NY 10029 |
Fergus Fleming | director, officer: Chief Technical Officer | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
Chirag R. Parikh | director | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
Erik Lium | director | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
James Renwick Mccullough | director, officer: Chief Executive Officer | C/O RENALYTIX PLC, FINSGATE, 5-7 CRANWOOD STREET, LONDON X0 EC1V 9EE |
From GuruFocus
By Marketwired • 06-14-2024
By GuruFocus Research • 02-08-2024
By Marketwired • 10-08-2024
By GuruFocus Research • 02-08-2024
By GuruFocus Research • 02-08-2024
By PRNewswire • 11-20-2024
By GuruFocus Research • 02-08-2024
By Marketwired • 08-03-2023
By sperokesalga sperokesalga • 06-05-2023
By GuruFocus Research • 05-16-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.